Clinical proof of Streptococcus thermophilus

In addition, Saavedra, who conducted an experiment: 55 hospitalized infants fed with Streptococcus thermophilus and Bifidobacterium (daily 200 million viable cells), showing good results. Take these two probiotic groups, only 7% of infant diarrhea, diarrhea, however, there are 31% of infants in the placebo group (p = 0.035). Take these two probiotic groups, only 3 (10%) of infant faeces rotavirus, however, found in the placebo group, there are 10 (39%) of infant stool rotavirus (level = 0.025). Another clinical trial is conducted in 70 overweight adults. These people take the Enterococcus faecium and Streptococcus thermophilus. They drank 450 ml of yogurt fermentation using these two strains. After 8 weeks, LDL cholesterol in their blood to reduce by 8.4% (p <0.05) fibrin concentration was higher.
Read more：http://www.acid-lactic-bacteria.com/lactobacillus/Streptococcus-Thermophilus/

Lactobacillus acidophilus - Health effects

Adjust the intestinal flora balance, inhibit the proliferation of undesirable intestinal microbes. Lactobacillus acidophilus against pathogenic microorganisms antagonistic. Lactobacillus acidophilus can secrete anti-biotin-like substances (Lactobacillus acidophilus streptozotocin (acidolin) and acidophilic bacteria hormone (acidophilin), lactobacillus (1aetocidon)), the antagonism of intestinal pathogens. Lactobacillus acidophilus (of Lactobacillus acidophilus, referred to as A) and Bifidobacterium Lactobacillus (Bifidobacterium, referred to as B) a mixture of leaven. The intake contains these two viable dairy foods on the digestive organs is good, especially patients with gastrointestinal dysfunction, gastrointestinal dysfunction in infants and some long-term oral antibiotics, eating food containing the fermentation of the two viable milk, you can quickly make to restore the normal balance of intestinal flora, inhibit the proliferation of spoilage bacteria, so has the role of good nutrition and health.
Read more：http://www.acid-lactic-bacteria.com/lactobacillus/Lactobacillus-Acidophilus-dual-coated/

Rapamycin Profile

Sirolimus (Rapamycin, RAPA, RPM), also known as Sirolimus is a macrolide antibiotic, can be used for low-dose hormone and F rapamycin the treatment FSGSK506 structurally similar. Rapamycin was initially to study as a low-toxicity antifungal rapamycin has immunosuppressive effects, 1989, rapamycin as a treatment of organ transplant rejection drug trial in 1977 found that, at present (2010), rapamycinthe I and Phase II clinical trial has ended, phase III clinical trials are ongoing. Formula of rapamycin for C51H79NO13 991KD molecular weight, as a white crystalline solid, melting point 183-185 ℃, lipophilic, dissolved in organic solvents such as methanol, ethanol, acetone, chloroform, very slightly soluble in water, almost insoluble in ether. Effect from animal experiments and clinical application of rapamycin is an effective, low toxicity, renal toxicity of a new immunosuppressant.
Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Rapamycin/

The Pecautions of Fusidic Acid

                                                                                                                                     

 Befor you use Fusidic Acid Tell your doctor if you have: pre-existing illness, infections, allergies (especially to any antibiotics). Fusidic Acid should be used only if clearly needed during pregnancy. Discuss therisks and benefits with your doctor. Fusidic Acid  has been found in breast milk. Consult your doctor before breast-feeding. If you miss a dose, apply it as soon as remembered; do not apply it ifit is near the time for the next dose, instead, skip the missed dose and resume your usual dosing schedule . Do not "double-up" the dose to catch upIf the condition for which this was prescribeddoes not improve or becomes worse after a few days, notify your doctor.
Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Fusidic-Acid/

The Side Effect of Fusidic Acid

Befor you use Fusidic Acid, Tell your doctor of any over-the-counter or prescription medicine you may take including: antibiotics, skin products. Do not start or stop any medicine without doctor or pharmacist approval.Fusidic Acid  may initially cause mild irritation, burning, or redness. If these effects continue or become worse notify your doctor. Tell your doctor immediately if any of these serious side effects occur: swelling, rash. If you notice other effects not listed above, contact your doctor or pharmacist.
Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Fusidic-Acid/

Bacitracin in History

The drug's unique name derives from the fact that it was isolated by John T. Goorley from a girl named Tracy:
One strain isolated from tissue debrided from a compound fracture of the tibia was particularly active. We named this growth-antagonistic strain for the patient, "Tracy I." When cell-free filtrates of broth cultures of this bacillus proved to possess strong antibiotic activity and to be non-toxic, further study seemed warranted. We have called this active principle "Bacitracin." It was approved by FDA in 1948.Synthesis
Bacitracin is synthesised via what is called nonribosomal peptide synthetases (NRPSs), which means that ribosomes are not involved in its synthesis.bacABC is involved in synthesis.
Main article: Bactoprenol phosphate
Bacitracin interferes with the dephosphorylation of the C55-isoprenyl pyrophosphate, a molecule that carries the building-blocks of the peptidoglycan bacterial cell wall outside of the inner membrane.
Bacitracin has been claimed to be a protein disulfide isomerase inhibitor in cells, but this is disputed by in vitro studies.
Read more：

http://www.acid-lactic-bacteria.com/bulk-drug/Bacitracin/

Hygromycin B basic information

Hygromycin B (Hygromycin B) is a by Streptomyces (Streptomyces hygroscopicus) produce antibiotics, aminoglycoside antibiotics is one of the micro-brown powder. Hygromycin B can inhibit the bacteria, fungi and some higher eukaryotic protein synthesis within the cell to kill these organisms. Hygromycin B is soluble in methanol, ethanol and water, but in ether, chloroform or benzene, almost insoluble. Hygromycin B was in the 1950s found that when used as animal drugs. And now it is still as insect pest drug is added chicken and pig feed. Used to generate hygromycin Streptomyces in 1953 was the first time isolated from soil and obtain pure culture. Hygromycin B resistance gene discovery related to the early 80s in the 20th century

Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Hygromycin-B/

Hygromycin B drug interactions

Treatment period. Prohibit the application of ear toxicity with drugs such as aminoglycoside, erythromycin and other antibiotics. In addition, the multi-product market to premix formulations, should be used to do hygromycin B titer units of measurement. Laboratory as a chemical reagent used. Our main research work carried out as follows, to the following specifications: 1, produced by the natural separation of bacteria, UV mutagenesis, fast processing and chemical mutagens EMS treatment, the fermentation units from 150-200U/mL to 1000-1500U/mL; and regeneration by protoplasts, spores and protoplasts with UV treatment and the optimization of fermentation medium ratio, the fermentation units in 2500-300U/mL, obtained by the strain breeding bacteria than the original starting types of 15-20 times the yield strain. 2, fermentation of, by the fermentation medium such as carbon, ammonia source, inorganic salts such as the ratio of research, especially the use of uniform design to optimize the culture medium and fermentation conditions such as temperature, pH, aeration, seed quality preferred to substantial increase in fermentation units, and identified a set of feasible fermentation process route. Amplified by the fermentation test, in which units of four batches of fermentation tank 200L average 276U/mL, up 3194U/mL, 2 吨 tank in an average of three batches 2226U/mL.
Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Hygromycin-B/

Streptococcus Thermophilus development background

Ongoing research and experimentation have improved the Streptococcus thermophilus strain even beyond its natural beneficial state. This improved strain is responsible for the consistent taste and texture of many dairy products. It also provides stable fermentation and a resilience to bacteriophage.
Streptococcus thermophilus also produces exopolysaccharides. These are essential to the texture of fermented milk products and also to the production of reduced-fat dairy products that maintain similar characteristics to their full-fat counterparts. One of Streptococcus thermophilus' unique abilities is that it can break down casein, the protein in dairy products like cheese. It reduces them into small peptides and amino acids that are required for the maturation of textures and flavors in reduced-fat cheeses. Different bacterial strains produce cheeses with differing characteristics. Streptococcus thermophilus, for example , produces a low-moisture cheddar cheese with a minimal level of bitterness, good for very mild cheddar cheese. However, by combining bacterial strains with varying characteristics, a high quality, reduced-fat cheddar cheese may be produced that is very similar to regular , full-fat cheddar.
Read more：http://www.acid-lactic-bacteria.com/lactobacillus/Streptococcus-Thermophilus/

bifidobacterium bifidum benefits

bifidobacterium bifidum can Diarrhea Treatment and Cancer Prevention.Probiotics such as B. bifidum are especially effective in the treatment of diarrhea, including infectious diarrhea and diarrhea associated with antibiotic use. The probiotics are even safe for children with diarrhea. The restoration of bacterial symbiosis within the gastrointestinal tract as a result of probiotic supplementation results in a decrease in stool frequency, fecal weight and abdominal cramps.
The article "Bifidobacterium as Probiotic Agents - Physiological Effects and Clinical Benefits" states that bacterial irregularity of the intestinal flora influences the creation of cancer cells by producing enzymes that transform normal cells into active carcinogens. Harmful bacteria in the colon promote tumor production and tumor transformation in the gut. Evidence suggests that probiotics such as B. bifidum protect the host from activities within the body that cause the growth and transformation of healthy cells into cancer cellsRead more：http://www.acid-lactic-bacteria.com/lactobacillus/Bifidobacterium-Bifidum/

Examples of rapamycin

Inhibition of the target of rapamycin signalling pathway by genetic or pharmacological intervention extends lifespan in invertebrates, including yeast, nematodes and fruitflies.Researchers reported that rapamycin extended median and maximal lifespan of both male and female mice when fed beginning at 600 days of age. On the basis of age at 90% mortality, rapamycin led to an increase of 14% for females and 9% for males. The effect was seen at three independent test sites in genetically heterogeneous mice, chosen to avoid genotype-specific effects on disease susceptibility. Disease patterns of rapamycin-treated mice did not differ from those of control mice. In a separate study, rapamycin fed to mice beginning at 270 days of age also increased survival in both males and females. Thus, rapamycin may extend lifespan by postponing death
from cancer, by retarding mechanisms of ageing, or both.

Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Rapamycin/

Target of rapamycin as a novel antitumor target

In mammals, target of rapamycin is best known to regulate translation through the ribosomal protein S6 kinases (S6Ks) and the eukaryotic translation initiation factor 4E-binding proteins. Consistent with the contribution of translation to growth, target of rapamycin regulates cell,
organ, and organismal size. The identification of the tumor suppressor proteins tuberous sclerosis1 and 2 (TSC1 and 2) and Ras-homolog enriched in brain (Rheb) has biochemically linked the target of rapamycin and phosphatidylinositol 3-kinase (PI3K) pathways, providing a mechanism for
the crosstalk that occurs between these pathways. Target of rapamycin is emerging as a novel antitumor target, since the target of rapamycin inhibitor rapamycin appears to be effective against tumorsresulting from aberrantly high PI3K signaling.

Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Rapamycin/

Bifidobacterium Bifidum overview

Bifidobacterium bifidum is one member of the Bifidobacterium family that is believed to be strictly of human origin. There are others of this family that are strictly of animal origin and still others that can be found in both human and animal.
Although Bifidobacterium bifidum is not one of the largest numbered of the Bifidobacterium family to be found in adult humans (it makes up around 2% of the Bifidobacterium1) it is believed to somehow have a clear ecological advantage in adults1.
Bifidobacterium bifidum has been shown to play an important part in the fermentation of Galactooligosaccharides2.Read more：http://www.acid-lactic-bacteria.com/lactobacillus/Bifidobacterium-Bifidum/

Rapamycin's Complexes-rapamycin1

 Rapamycin Complex 1 (Rapamycin1) is composed of Rapamycin , regulatory-associated protein of Rapamycin (Raptor), mammalian LST8/G-protein β-subunit like protein (mLST8/GβL) and the recently identified partners PRAS40 and DEPTOR. This complex is characterized by the classic features of Rapamycin by functioning as a nutrient/energy/redox sensor and controlling protein synthesis.The activity of this complex is stimulated by insulin, growth factors, serum, phosphatidic acid, amino acids (particularly leucine), and oxidative stress.

Rapamycin1 is inhibited by low nutrient levels, growth factor deprivation, reductive stress, rapamycin, and farnesylthiosalicylic acid (FTS).The two best characterized targets of mTORC1 are p70-S6 Kinase 1 (S6K1) and 4E-BP1, the eukaryotic initiation factor 4E (eIF4E) binding protein 1.

Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Rapamycin/

What is Bifidobacterium bifidum

Bifidobacterium bifidum is one of many bacteria found in the human body. The digestive system is home to an estimated 500 different species of bacteria, including members of the Bifidobacterium, Lactobacillus, Clostridium, Fusobacterium, and Bacteroids families. In addition to these good bacteria, the human gut flora also includes a number of strains of yeast or fungi. Although the largest population of Bifidobacterium bifidum is located in the digestive system, lesser amounts are also found in the mouth, breast milk, and the vagina.
There are many benefits of good bacteria in the digestive system. Bifidobacterium bifidum and other probiotics assist the body in breaking down undigested carbohydrates that could otherwise not be utilized. The bacteria then turn these carbohydrates into substances called short chain fatty acids. Short chain fatty acids assist the body by reducing harmful bacteria, providing nutrients and energy, and protecting against fluid loss.Read more：http://www.acid-lactic-bacteria.com/lactobacillus/Bifidobacterium-Bifidum/

The role of bacitracin zinc

Bacitracin Zinc promote the body's digestion and absorption of zinc bacitracin to animal intestinal wall thinning, increased intestinal permeability changes in intestinal metabolism of the environment and to promote digestion and absorption of nutrients. According to reports, the use of chicken fed zinc bacitracin and bacitracin zinc with not feeding the chickens, the former wall was thinner, and fed bacitracin zinc, make animal intestinal ammonia and formation of toxic amines significantly reduce and maintain normal levels of alkaline phosphatase in the digestive tract, in order to facilitate nutrient digestion and absorption. Norwegian Air Hal ladder De Boshi small cock in diets 1 0 0 mg / bacitracin zinc experiments have shown that arginine can improve the utilization of 1. 1, histidine 2. O 9 / 6, isoleucine 1. 4 9 / 6, leucine 1. 2 9 / 6, lysine 2. 2 9 / 6, methionine 1. 2, phenylalanine 0. 6, threonine 2. O, Val 1. 1, cystine 1. 99 / 6, tyrosine 0. 1, creatinine 0. 1, proline 0. 39 / 6, serine 1. 9. That in feed zinc bacitracin, can significantly improve the utilization of animal nutrients, thereby promoting the growth performance of the play.Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Bacitracin-zinc/

Bacitracin adverse reactions

Bacitracin following adverse reactions may occur, local bacitracin infusion for abdominal surgery or medication in the body cavity infection is large, may have traces of absorption, causing kidney toxicity may occur. Allergic reactions, local skin itching, rash, redness or other irritation, generally mild. Occasional local use after severe systemic allergic reaction. Systemic bacitracin, can cause severe kidney toxicity, renal tubular damage is the most obvious parts of the glomerular filtration function has also been inhibited, abnormalities found in the urine of the first administration of 3 to 4 days to 5 7 days and reached the peak, although the future to continue medication, the situation is sometimes counter-improved. With proteinuria, urinary tube, etc. appear, also showed impaired renal function, severe acute tubular necrosis may occur and death. Because of its toxicity, and the other has the same effect of the emergence of the low toxicity of antibiotics, it is currently the only topical product. Topical application of bacitracin zinc ointment when there are very few patients have allergic reactions.Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Bacitracin/

What is bacitracin zinc

Bacitracin zinc is light brown or tan powder; a special smell. Bacitracin zinc is a peptide antibiotic, against Gram-positive bacteria with bactericidal action, the mechanism of the inhibition of bacterial wall synthesis of bacteria, but also with sensitive bacterial cell membrane, damage the cell membrane integrity, leading to an outflow of important material within cells. Inhibit Gram-positive bacteria and some Gram-negative bacteria; bacitracin-resistant bacteria is slow, and other antibiotics, no cross-resistance. Promote animal growth, improve feed conversion rates. Oral bacitracin zinc is almost no absorption, most within 2 days with the feces. Bacitracin and penicillin, streptomycin, neomycin, chlortetracycline, polymyxin, which are synergistic antibacterial effect. The goods and olaquindox, kitasamycin, virginiamycin, En La neomycin incompatibility exists. For Gram-positive bacteria and penicillin-resistant Staphylococcus aureus infection.Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Bacitracin-zinc/

teicoplanin for the treatment of G + bacterial infections

Third Affiliated Hospital of Sun Yat-sen Chang-day care such as evaluation of teicoplanin treatment of G + bacteria infection efficacy and safety, the use of randomized controlled and open trials to vancomycin as the control. Completed cases, 60 cases in which the test group of 30 patients, teicoplanin 0.2 to 0.4 grams a day, intravenously; the control group of 30 patients, vancomycin 0.5 g, 3 times a day intravenously. Treatment lasted 7 to 14 days. Results, the test group cure rate, efficient bacterial clearance rates were 50%, 80% and 83.3% in the control group were 46.7%, 76.7% and 76.7%, no significant difference between the two groups. Adverse reaction rates were 10% and 13.3%, no significant difference between the two groups. From this view, teicoplanin therapy safe and effective G + bacterial infection. Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Teicoplanin/

Teicoplanin for the treatment of G + bacterial infections

Teicoplanin adverse reactions are mainly elevated liver transaminases, rash, neutropenia, and gastrointestinal tract, ear, kidney toxicity rare. Although glycopeptide antibiotics has been the treatment of bacterial infections of the G + effective drug, but in recent years, glycopeptide-sensitive Staphylococcus aureus (GISA), vancomycin-resistant enterococci (VRE), multidrug-resistant Streptococcus pneumoniae (DRSP ) and other infections are a growing trend, so take an alternative drug or drug combination in order to more effectively control the GISA, VRE, and DRSP infections. However, the combination of adverse reactions increase is the main drawback, especially an increase in renal toxicity and neurotoxicity. In combination with aminoglycosides, teicoplanin than other glycopeptide antibiotics on renal function is much smaller, and the glycopeptide antibiotics rarely cause allergic reactions caused by "Reds syndrome." Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Teicoplanin/